Disease-related variables | Hypertension | MI | First CVD event | |||
HR | p Value | HR | p Value | HR | p Value | |
Gender | 1.29 | 0.19 | 2.48 | 0.01 | 1.55 | 0.01 |
Age at onset of psoriasis | 1.01 | 0.08 | 1.00 | 0.74 | 1.00 | 0.73 |
Age at onset of PsA | 0.98 | 0.13 | 1.00 | 0.86 | 0.99 | 0.14 |
No of actively inflamed joints | 1.01 | 0.61 | 1.02 | 0.41 | 1.00 | 0.98 |
No of clinically deformed joints | 1.00 | 0.99 | 1.00 | 0.85 | 1.00 | 0.80 |
NSAIDs ever used | 1.57 | 0.30 | 2.53 | 0.37 | 1.27 | 0.50 |
Intra-articular steroid ever used | 1.20 | 0.34 | 1.24 | 0.56 | 1.23 | 0.23 |
DMARDs ever used | 1.21 | 0.31 | 0.86 | 0.64 | 1.11 | 0.51 |
Methotrexate ever used | 1.39 | 0.08 | 0.75 | 0.40 | 1.17 | 0.34 |
Biological agents ever used | 0.62 | 0.63 | 0.41 | 0.38 | ||
Steroids ever used | 1.37 | 0.15 | 1.48 | 0.29 | 1.30 | 0.18 |
Immunosuppressive drugs ever used | 1.31 | 0.14 | 0.79 | 0.47 | 1.15 | 0.40 |
Diabetes | 3.40 | <0.01 | 1.79 | 0.36 | 2.49 | 0.01 |
Daily alcohol use | 1.55 | 0.38 | 0.88 | 0.91 | 1.62 | 0.31 |
Current smoker | 0.46 | 0.29 | 15.89 | 0.01 | 1.03 | 0.96 |
Logarithm of uric acid | 1.47 | 0.15 | 2.48 | 0.09 | 1.49 | 0.08 |
Logarithm of triglycerides | 1.44 | <0.01 | 1.52 | 0.03 | 1.47 | <0.01 |
Logarithm of cholesterol | 1.26 | 0.22 | 1.40 | 0.25 | 1.31 | 0.10 |
ESR | 1.00 | 1.00 | 1.01 | 0.34 | 1.00 | 0.69 |
Interaction of ESR and gender | 1.01 | 0.14 | 1.01 | 0.58 | 1.01 | 0.15 |
PASI score (base category = 0) | 0.02 | 0.19 | <0.01 | |||
0<PASI⩽10 | 0.85 | 0.67 | 1.84 | 0.56 | 0.91 | 0.79 |
10<PASI⩽20 | 0.72 | 0.51 | 1.23 | 0.87 | 0.68 | 0.42 |
PASI >20 | 2.27 | 0.08 | 5.59 | 0.13 | 2.70 | 0.02 |
CVD, cardiovascular disease; DMARDs, disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; HR, hazard ratio; MI, myocardial infarction; NSAIDs, non-steroidal anti-inflammatory drugs; PsA, psoriatic arthritis; PASI, Psoriasis Area and Severity Index.